[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367205-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-367205-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","regulation-of-granzymes-a-and-b-by-high-risk-hpv-impact-on-immune-evasion-and-carcinogenesis","Regulation of Granzymes A and B by High-Risk HPV - Impact on Immune Evasion and Carcinogenesis","","Rising global cancer incidence includes a substantial fraction driven by human papillomavirus (HPV), especially high-risk types 16 and 18, which promote oncogenesis by reshaping host immunity. High-risk HPVs target immune effectors such as granzymes A and B and MHC-I, weakening recognition and clearance of infected and transformed cells. Mechanisms include downregulating tumor suppressors (p53, pRB) and suppressing granzyme- and antigen-presentation-linked CTL and NK responses. The review examines how viral oncoproteins E6 and E7 interfere with granzyme-mediated cytotoxicity and MHC-I–dependent antigen presentation, highlighting potential therapeutic opportunities.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/regulation-of-granzymes-a-and-b-by-high-risk-hpv-impact-on-immune-evasion-and-carcinogenesis/367205/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/regulation-of-granzymes-a-and-b-by-high-risk-hpv-impact-on-immune-evasion-and-carcinogenesis/367205.png","ImageObject",300,407,{"name":42,"@type":43},"Asher","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How do high-risk HPV infections contribute to immune evasion and cancer development?","Question",{"text":63,"@type":64},"High-risk HPVs manipulate host immune responses, weakening elimination of virus-infected and transformed cells. This enables persistent infection and supports carcinogenesis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What roles do granzymes A and B play in cytotoxicity?",{"text":68,"@type":64},"Granzymes A and B promote apoptosis through complementary pathways. Granzyme A can trigger caspase-independent cell death, while granzyme B initiates caspase-dependent apoptotic signaling.",{"name":70,"@type":61,"acceptedAnswer":71},"How do HPV E6 and E7 oncoproteins affect tumor suppressors and immune functions?",{"text":72,"@type":64},"E6 and E7 deactivate tumor suppressors such as p53 and Rb, obstructing host apoptotic machinery. They also interfere with granzyme-mediated cytotoxicity and antigen presentation linked to MHC-I.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},367205,1790194979,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Review  \nRegulation of Granzymes A and B by High-Risk HPV: Impact on Immune Evasion and Carcinogenesis  \nMashego Nathan Maleka, Zukile Mbita  and Vivian Morafo *  \nAcademic Editor: RobertaGonnella  \nReceived: 6 December 2024  \nRevised: 24 January 2025  \nAccepted: 28 January 2025  \nPublished: 3 February 2025  \nCitation: Maleka, M.N.; Mbita, Z.; Morafo, V. Regulation of GranzymesA and Bby High-Risk HPV: Impact on Immune Evasion and Carcinogenesis. Viruses 2025, 17, 221. [https://](https://)[ ](https://)[doi.org/10.3390/v17020221](doi.org/10.3390/v17020221)  \n[Copyright:](Copyright:) © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \nDepartment of Biochemistry, Microbiology and Biotechnology, School of Molecular and Life Sciences, Private Bag X 1106, Sovenga, Polokwane 0727, South Africa; [202002762@keyaka.ul.ac.za](202002762@keyaka.ul.ac.za) (M.N.M.);  \n[zukile.mbita@ul.ac.za](zukile.mbita@ul.ac.za) (Z.M.)  \n* [Correspondence: vivian.morafo@ul.ac.za](Correspondence: vivian.morafo@ul.ac.za); Tel.: +27-(0)-15-268-3014  \nAbstract: The number of new cancer cases is soaring, and currently, there are 440.5 per 100,000 new cases reported every year. A quarter of these are related to human papillomavirus (HPV) infections, particularly types 16 and 18 . These include oropharyngeal, anal, vaginal, and penile cancers. A critical aspect of their oncogenic potential lies in their ability to manipulate host immune responses, facilitating immune evasion and carcinogenesis. High-risk HPVs target key immune components like granzymes A and B and MHC-I, which are crucial for the elimination of virus-infected and transformed cells, thereby weakening immune surveillance. Evidence suggests that high-risk HPVs downregulate the expression of tumor suppressors, such as p53 and pRB, and the activity of these immune components, weakening CTL and NK cell responses, thus enabling persistent infection and carcinogenesis. We discuss the implications of granzyme and MHC-I dysregulation for immune evasion, tumor progression, and potential therapeutic strategies. This review further explores the regulation of granzyme A, B, and MHC-I by high-risk HPVs, focusing on how viral oncoproteins, E6 and E7, interfere with granzyme-mediated cytotoxicity and antigen presentation. The complex interplay between high-risk HPVs, granzyme A, granzyme B, and MHC-I may provide insights into novel approaches for targeting HPV-associated cancers.  \nKeywords: high-risk HPV; cancer; E6 and E7 oncoproteins; granzyme A and B; MHC-I; carcinogenesis; apoptosis; immune evasion  \n1. Introduction  \nThe ubiquitous DNA virus known as the human papillomavirus (HPV) is responsible for several illnesses, including various cancers [1] . The most prominent of these is cervical cancer, which continues to rank among the main causes of cancer-related deaths linked to HPV infections globally. According to Lei et al. [2], HPV is also the cause of other cancers, such as those of the neck, mouth cavity, anal, and oropharyngeal tissues. The World Health Organization [2] reports that each year in Africa, the human papillomavirus causes over 10,702 new cases of the disease as well as 5870 fatalities. Because HPV has a strong correlation with female cancer cases, it has a significant impact on public health. Although more than 200 different strains of HPV have been identified, the strains that are most closely linked to carcinogenesis are the high-risk varieties, specifically HPV-16 and HPV-18 . These high-risk strains cause recurring infections, which eventually raise the possibility of cancer. When the virus eludes the immune system and the infected cells multiply uncontrollably, cancers caused by HPV occur. The ability of the virus t","cbCaieSG6MfTaKqL","https://ap.wps.com/l/cbCaieSG6MfTaKqL","pdf",994935,22,"English","# Introduction\n## Granzymes and immune surveillance\n## HPV-mediated immune evasion via MHC-I and tumor suppressors","[{\"question\":\"How do high-risk HPV infections contribute to immune evasion and cancer development?\",\"answer\":\"High-risk HPVs manipulate host immune responses, weakening elimination of virus-infected and transformed cells. This enables persistent infection and supports carcinogenesis.\"},{\"question\":\"What roles do granzymes A and B play in cytotoxicity?\",\"answer\":\"Granzymes A and B promote apoptosis through complementary pathways. Granzyme A can trigger caspase-independent cell death, while granzyme B initiates caspase-dependent apoptotic signaling.\"},{\"question\":\"How do HPV E6 and E7 oncoproteins affect tumor suppressors and immune functions?\",\"answer\":\"E6 and E7 deactivate tumor suppressors such as p53 and Rb, obstructing host apoptotic machinery. They also interfere with granzyme-mediated cytotoxicity and antigen presentation linked to MHC-I.\"}]","Regulation of Granzymes A and B by High-Risk HPV - Impact on Immune Evasion and Carcinogenesis | PDF",1790169702,55,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5e34273b3779718a340b2ce81876e473.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b924afa3455fea620cef3f02d9c3052b.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/11d63ac41f8db4737ca82f65ae78c7a2.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2f230200c06d265a171dd56cf2cc91db.webp",980,1385]